Appalanaidu Sasapu
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Assistant Professor
Also affiliated: BC Cancer Agency (2016); University of Arkansas Medical Center (2017–2018); Central Arkansas Veterans Healthcare System (2016); Winthrop Rockefeller Foundation (2015–2021); Louisiana State University Health Sciences Center New Orleans (2012–2013)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Appalanaidu Sasapu's research focuses on hematologic malignancies and rare bleeding disorders. Sasapu has published on intravascular large B-cell lymphoma, including its diagnostic challenges. Other work includes studies on diffuse large B-cell lymphoma, specifically salvage radiation treatment after CAR T-cell therapy and remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma with brentuximab vedotin. Sasapu also investigates acquired hemophilia A in patients with multiple sclerosis, and atypical hemolytic uremic syndrome, examining clinical-laboratory-genetic profiles and outcomes with a focus on eculizumab use. Further research explores improved clinical outcomes with busulfan-based conditioning for allogeneic stem cell transplantation. Sasapu's scholarship metrics include an h-index of 7, with 53 total publications and 1,611 total citations.
Metrics
- h-index: 7
- Publications: 53
- Citations: 1,630
Selected Publications
-
Acquired Hemophilia A in a Patient With Multiple Sclerosis (2022)
-
Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma (2021)
-
Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin (2021)
-
Treatment Strategies and Outcomes for Patients with Peripheral T-Cell Lymphoma and Its Subtypes (2020)
-
Hemophagocytic lymphohistiocytosis in adults (2020)
-
Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (2020)
-
Acquired hemophilia A (2019)
-
Retrospective Review of Patients with Large Granular Lymphocyte (LGL) Leukemia in a Single Institution over a Period of 11 Years (2019)
-
Potentially Modifiable Risk Factors for 30‐Day Readmission in Adults with Sickle Cell Disease: A National Database Study (2019)
-
Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis (2019)
-
Epidemiology and Factors Affecting Mortality of Hospitalized Patients with Disseminated Intravascular Coagulation in the United States (2019)
-
Eltrombopag Following Chemotherapy and G-CSF+/- Plerixafor for Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Lymphoma and Myeloma Patients (2019)
-
Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphoma (2019)
-
Assessing advance directive (AD) completion rate in inpatient hematology unit. (2019)
-
Vitamin B12 deficiency mimicking acute leukemia (2019)
Collaboration Network
Top Collaborators
- Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma
- Acquired Hemophilia A in a Patient With Multiple Sclerosis
- Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin
- Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin
- Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin
- Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma
- Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma
- Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma
- Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma
- Acquired Hemophilia A in a Patient With Multiple Sclerosis
Similar Researchers
Based on overlapping research topics